Hydroxyapatite

Boka Launches at CVS Pharmacy

Retrieved on:

Tuesday, March 12, 2024

Tooth enamel, Coconut oil, Dentistry, CVS, Confusion, Calcium, CVS Pharmacy, Social media, Pharmacy, CPG, NASA, Hydroxyapatite, Personal care

NEW YORK, March 12, 2024 /PRNewswire/ -- Boka, the mindful oral care brand on a mission to create products with proven ingredients and feel-good formulas, announced nationwide expansion into CVS Pharmacy. The premier pharmacy retailer will be selling Boka's two best-selling products, Ela Mint Toothpaste and Refresh Mint Whitening Toothpaste, at 6,700 CVS Pharmacy stores nationwide and on cvs.com.

Key Points:

The premier pharmacy retailer will be selling Boka's two best-selling products, Ela Mint Toothpaste and Refresh Mint Whitening Toothpaste , at 6,700 CVS Pharmacy stores nationwide and on cvs.com .
"Launching into nearly 7,000 CVS Pharmacy stores nationwide as the first oral care brand powered by n-HA marks a huge milestone for the brand," said Trish Kozlak, Head of Retail Expansion at Boka.
Boka's retail expansion into CVS Pharmacy underscores the brand's commitment to offering customers access to the latest oral health advancements as Boka will be the first oral care brand sold at CVS Pharmacy containing Nano-Hydroxyapatite (n-HA).
To learn more about Boka and its offerings, please visit www.boka.com and follow along on social media @boka .

Boka Announces Brick & Mortar Partnership With Ulta Beauty

Retrieved on:

Monday, March 20, 2023

Dentistry, Partnership, Travel, CPG, Medicine, Social media, Science, Ginger, Ulta, Hydroxyapatite, Beauty, Acquisition, NASA, Nature, Growth, Beauty salon, Cosmetics, Amazon, Ulta Beauty

NEW YORK, March 20, 2023 /PRNewswire/ -- Today, Boka, the personal care brand on a mission to deliver innovative oral care backed by modern science and nature, is proud to announce its first large-scale, brick-and-mortar exclusive partnership with Ulta Beauty, the nation's largest beauty retailer. Boka debuted three of its best-selling products, as well as a travel-sized exclusive, in 800 Ulta Beauty stores nationwide and on Ulta.com.

Key Points:

Boka debuted three of its best-selling products, as well as a travel-sized exclusive, in 800 Ulta Beauty stores nationwide and on Ulta.com.
Boka is the first oral care brand sold at Ulta Beauty containing its pioneer ingredient, Nano-Hydroxyapatite (n-HA).
The four products now available at Ulta Beauty include:
Ela Mint Toothpaste ($12): Ela Mint is unlike any other toothpaste by design.
"We are thrilled to launch Boka in Ulta Beauty, our first-ever brick-and-mortar retail partner," said Nisha Karna, Director of Brand at Boka.

At 6.7% CAGR, Hydroxyapatite Market Size is Expected to Reach USD 3722.3 Million by 2028, says Brandessence Market Research

Retrieved on:

Wednesday, July 20, 2022

Awareness, Growth, Ageing, Technology, Hydroxyapatite, Population, Income, Medicine, Ceramic

The sudden surge in the demand is leading to an increase in the portfolio products and manufacturing across the world and thereby enhanced the demand for the hydroxyapatite market share.

Key Points:

The sudden surge in the demand is leading to an increase in the portfolio products and manufacturing across the world and thereby enhanced the demand for the hydroxyapatite market share.
Furthermore, there is an introduction of the new healthcare services in many of the developed countries and that is expected to fuel this growth.
A big growth driver for the hydroxyapatite market 2022 is the rise in customer awareness about the bioactive ceramics.
On Special Requirement Hydroxyapatite Market Report is also available for below region:

At 6.7% CAGR, Hydroxyapatite Market Size is Expected to Reach USD 3722.3 Million by 2028, says Brandessence Market Research

Retrieved on:

Wednesday, July 20, 2022

Awareness, Growth, Ageing, Technology, Hydroxyapatite, Population, Income, Medicine, Ceramic

The sudden surge in the demand is leading to an increase in the portfolio products and manufacturing across the world and thereby enhanced the demand for the hydroxyapatite market share.

Key Points:

The sudden surge in the demand is leading to an increase in the portfolio products and manufacturing across the world and thereby enhanced the demand for the hydroxyapatite market share.
Furthermore, there is an introduction of the new healthcare services in many of the developed countries and that is expected to fuel this growth.
A big growth driver for the hydroxyapatite market 2022 is the rise in customer awareness about the bioactive ceramics.
On Special Requirement Hydroxyapatite Market Report is also available for below region:

Insights on the Medical Ceramics Global Market to 2027 - by Type, Application, End-user and Region - ResearchAndMarkets.com

Retrieved on:

Monday, July 18, 2022

Some of the commonly used medical ceramics include bio-inert ceramics, which are manufactured using alumina and zirconia, bioactive ceramics manufactured using Hydroxyapatite and glass, and bioresorbable and piezoelectric ceramics.

Key Points:

Some of the commonly used medical ceramics include bio-inert ceramics, which are manufactured using alumina and zirconia, bioactive ceramics manufactured using Hydroxyapatite and glass, and bioresorbable and piezoelectric ceramics.
Key Questions Answered in This Report:
How has the global medical ceramics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global medical ceramics market?
What is the structure of the global medical ceramics market and who are the key players?

New Liquid Core® SMILE™ Gum with Activated Charcoal and Hydroxyapatite

Retrieved on:

Thursday, June 9, 2022

DENVER, June 9, 2022 /PRNewswire/ -- Liquid Core® Gum Company announced the release of Liquid Core SMILE™ Gum today, offering a just-brushed clean mouth after meals, or when brushing isn't convenient. Featuring Activated Charcoal and Hydroxyapatite, a fluoride alternative, Liquid Core SMILE™ was formulated using ingredients clinically proven/shown to strengthen tooth enamel and improve oral health. Liquid Core SMILE™ Gum is part of the Liquid Core® Health & Wellness Collection. The launch of Liquid Core SMILE™ coincides with National Smile Month, a campaign focused on the benefits of good oral health.

Key Points:

Chewing Gum After Meals Improves Oral Health, Provides Cognitive Boost
DENVER, June 9, 2022 /PRNewswire/ -- Liquid Core Gum Company announced the release of Liquid Core SMILE Gum today, offering a just-brushed clean mouth after meals, or when brushing isn't convenient.
Featuring Activated Charcoal and Hydroxyapatite, a fluoride alternative, Liquid Core SMILE was formulated using ingredients clinically proven/shown to strengthen tooth enamel and improve oral health.
Liquid Core SMILE Gum is part of the Liquid Core Health & Wellness Collection.
Liquid Core Gum chewers understand the functional benefits of the brands, while Liquid Core SMILE offers an opportunity to bring people that do not currently chew gum into the functional gum category.

VySpine Announces FDA Clearance for LumiVy Lumbar IBF System

Retrieved on:

Tuesday, March 8, 2022

FDA, Health, Surgery, Medical Devices, IBF, FDA, Surgeon, Spine, Lordosis, Elasticity, Hydroxyapatite, CEO, Medical device

VySpine , a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its LumiVy Lumbar IBF System which is designed for use after lumbar discectomy in fusion procedures.

Key Points:

VySpine , a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its LumiVy Lumbar IBF System which is designed for use after lumbar discectomy in fusion procedures.
The LumiVy Lumbar IBF System features lumbar interbody fusion devices made from either PEEK Optima LT1 or PEEK Optima HA-Enhanced.
The LumiVy Lumbar IBF System is our latest innovation in a series of comprehensive interbody systems being developed by VySpine, said Tom McLeer, CEO of VySpine.
The LumiVy Lumbar IBF System also features IBF-S implants, which have self-drilling screws to aid in anchoring the device directly to the bone.

VySpine Announces FDA Clearance for ClariVy Cervical IBF System

Retrieved on:

Tuesday, February 1, 2022

Women, Biotechnology, Surgery, Health, FDA, Medical Devices, Hospitals, Consumer, IBF, CEO, Hydroxyapatite, ACDF, Lordosis, Spine, FDA, LT1, Elasticity, Surgeon, Optima, Medical device

VySpine , a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for the its ClariVy Cervical IBF System which is designed for use in anterior cervical discectomy with fusion (ACDF) procedures.

Key Points:

VySpine , a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for the its ClariVy Cervical IBF System which is designed for use in anterior cervical discectomy with fusion (ACDF) procedures.
The ClariVy Cervical IBF System features cervical interbody fusion devices made from either PEEK Optima LT1, or PEEK Optima HA-Enhanced.
The ClariVy Cervical IBF System is the first in a series of differentiated interbody systems being developed by VySpine, said Tom McLeer, CEO of VySpine.
The ClariVy Cervical IBF System also features IBF-S implants, which have self-drilling screws to aid in anchoring the device directly to the bone.

Kelyniam Global, Inc., Announces Strategic Licensing Agreement with Fin-ceramica faenza spa to Market Hydroxyapatite Cranial Implant in the U.S.

Retrieved on:

Wednesday, December 22, 2021

COLLINSVILLE, Conn., Dec. 22, 2021 /PRNewswire/ --Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial PEEK implants today announced that it has entered into a strategic licensing agreement with Fin-ceramica faenza spa to market the company's hydroxyapatite patient specific implant.

Key Points:

COLLINSVILLE, Conn., Dec. 22, 2021 /PRNewswire/ --Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial PEEK implants today announced that it has entered into a strategic licensing agreement with Fin-ceramica faenza spa to market the company's hydroxyapatite patient specific implant.
This bio-mimetic ceramic biomaterial is based on macro and micro porous Hydroxyapatite (HA), a major (70%) component of human bone.
"Our companies share a mutual passion of working closely with neurosurgeons to design and build complex implants for cranial and maxillo-facial applications.
Kelyniam will distribute the implant through its active salesforce of more than 50 representatives starting in January.

Global Hydroxyapatite Markets Report 2020: Focus on Nano Size, Micro Size, & Greater than Micrometers - ResearchAndMarkets.com

Retrieved on:

Wednesday, January 6, 2021

Biotechnology, Medical devices, Manufacturing, Health, Chemicals, Plastics, Minerals, Phosphate minerals, Biomaterials, Hydroxyapatite, Apatite

It presents a thorough and up-to-date global assessment of the technology, markets and business of hydroxyapatite.

Key Points:

It presents a thorough and up-to-date global assessment of the technology, markets and business of hydroxyapatite.
This report covers the technological, economic and business considerations of the hydroxyapatite industry, with analyses and forecasts provided for global markets.
Included in the report are descriptions of market forces relevant to the hydroxyapatite industry and their areas of application.
The hydroxyapatite market is further segmented based on its size: nano size, micro size and micrometer, and segmented into applications like dental, orthopedic and plastic surgery.